Amphastar Pharmaceuticals Newsroom

Earnings Preview: AMPH to Report Financial Results Post-market on November 06

$Amphastar Pharmaceuticals(AMPH.US)$ is scheduled to release its financial results post-market on November 06 ET. Earnings PreviewAnalysts estimate $Amphastar Pharmaceuticals(AMPH.US)$ to post

Futu NewsNov 1 09:00

Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 6, 2024

AccesswireOct 29 18:00

Capital One Financial Maintains Amphastar Pharmaceuticals(AMPH.US) With Buy Rating, Maintains Target Price $70

Futu NewsOct 19 00:31 · Ratings

Amphastar Pharmaceuticals: Strong Product Pipeline and Financial Position Justify Buy Rating

TipRanksOct 19 00:25 · Ratings

Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) Stock Is Going Strong: Is the Market Following Fundamentals?

Yahoo FinanceOct 16 23:51

Is Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) The Top Stock With Improving Technical Ratings According To Piper Sandler?

Yahoo FinanceOct 12 00:32

Amphastar Pharmaceuticals (NASDAQ:AMPH) Could Easily Take On More Debt

Simply Wall StOct 4 19:20

Implied Volatility Surging for Amphastar Pharmaceuticals (AMPH) Stock Options

Zacks Oct 3 19:50

Amphastar Pharmaceuticals' (NASDAQ:AMPH) Three-year Earnings Growth Trails the Stellar Shareholder Returns

Simply Wall StSep 15 20:17

Insider Sale: Director Floyd Petersen Sells Shares of Amphastar Pharmaceuticals Inc (AMPH)

InvestingSep 7 07:43

JP Morgan Shows Most Interest In Teva, Organon As Specialty Pharma Sector Exhibits Signs Of Stability

BenzingaSep 7 01:46

Organon Downgraded, Amneal Upgraded as J.P. Morgan Reviews Specialty Pharma

Seeking AlphaSep 6 20:39 · Ratings

Express News | Amphastar Pharmaceuticals: Armstrong, Genreach to Collaborate to Expand Distribution of Co’s Inhalation Product, Primatene Mist in Mainland China

BreakingsAug 31 04:35

Express News | Amphastar Pharmaceuticals: On Aug 28 Armstrong Pharmaceuticals & Hong Kong Genreach Limited Entered Into Distribution Agreement

BreakingsAug 31 04:35

Amphastar Pharmaceuticals to Present at the 2024 Wells Fargo Healthcare Conference

AccesswireAug 29 04:10

'Bottom-fishing' Ideas Within Piper Sandler's Universe of Stocks

Seeking AlphaAug 20 23:56

Stocks With Three Weeks of Improving Technicals by Piper Sandler

Seeking AlphaAug 20 23:26

Capital One Financial Maintains Amphastar Pharmaceuticals(AMPH.US) With Buy Rating, Maintains Target Price $70

Capital One Financial analyst Tim Chiang maintains $Amphastar Pharmaceuticals(AMPH.US)$ with a buy rating, and maintains the target price at $70.According to TipRanks data, the analyst has a success

Futu NewsAug 16 21:31 · Ratings

Amphastar Pharmaceuticals Poised for Growth: Strong Product Performance and Strategic Financial Health Drive Buy Rating

TipRanksAug 16 21:05 · Ratings

Amphastar Pharmaceuticals Insider Sold Shares Worth $736,550, According to a Recent SEC Filing

MT NewswiresAug 14 06:01